News

Fear of needles is one of health care’s most common, and most ignored, barriers.Millions of people experience anxiety or panic attacks at just the sight of a syringe. Some avoid routine vaccinations or postpone blood tests or IV treatments until symptoms worsen. Many who intend to donate blood never show up, held back by a fear they rarely admit aloud.This is not only a … [Read more...] about Virtual reality can make needles less scary

Compared with placebo, treatment with atropine 0.01% led to slower myopia progression in younger school-age children with low or pre-myopia, but this effect was not significant. … [Read more...] about Lower Atropine Doses May Have a Modest Effect on Progression in Low Myopia and Pre-Myopia

The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics.Yuvezzi (carbachol 2.75%/brimonidine tartrate 0.1% ophthalmic solution), formerly known as Brimochol PF, achieves effect after around 30 minutes and lasts for up to 10 hours, according to … [Read more...] about FDA approves Yuvezzi eye drop for presbyopia

A Change.org petition with more than 800 signatures is calling on the FDA to approve low-dose atropine to slow the progression of pediatric myopia.It comes after the FDA decided not to approve SYD-101 (0.01% atropine, Sydnexis) in October despite acknowledging the drug met its primary efficacy endpoint in a phase 3 study and had no safety or quality issues.The petition was … [Read more...] about Eye care practitioners urge FDA to approve low-dose atropine

Vitrectomy with ILM peeling for grade C PVR, glaucoma and dementia, metformin use and AMD, sleep insufficiency and retinal neurodegeneration, comparing AI models for ophthalmology case diagnosis. … [Read more...] about Weekly Journal Update — January 28, 2026